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Cross-disorder risk gene CACNA1C differentially modulates
susceptibility to psychiatric disorders during development and
adulthood
N Dedic1, ML Pöhlmann1, JS Richter1, D Mehta2,3, D Czamara2, MW Metzger1, J Dine1, BT Bedenk1, J Hartmann1,4, KV Wagner1, A Jurik5,
LM Almli6, A Lori6, S Moosmang5, F Hofmann5, CT Wotjak1, G Rammes7, M Eder1, A Chen1,8, KJ Ressler6,4, W Wurst9, MV Schmidt1,
EB Binder3,6 and JM Deussing1
Single-nucleotide polymorphisms (SNPs) in CACNA1C, the α1C subunit of the voltage-gated L-type calcium channel Cav1.2, rank
among the most consistent and replicable genetics ﬁndings in psychiatry and have been associated with schizophrenia, bipolar
disorder and major depression. However, genetic variants of complex diseases often only confer a marginal increase in disease risk,
which is additionally inﬂuenced by the environment. Here we show that embryonic deletion of Cacna1c in forebrain glutamatergic
neurons promotes the manifestation of endophenotypes related to psychiatric disorders including cognitive decline, impaired
synaptic plasticity, reduced sociability, hyperactivity and increased anxiety. Additional analyses revealed that depletion of Cacna1c
during embryonic development also increases the susceptibility to chronic stress, which suggest that Cav1.2 interacts with the
environment to shape disease vulnerability. Remarkably, this was not observed when Cacna1c was deleted in glutamatergic
neurons during adulthood, where the later deletion even improved cognitive ﬂexibility, strengthened synaptic plasticity and
induced stress resilience. In a parallel gene × environment design in humans, we additionally demonstrate that SNPs in CACNA1C
signiﬁcantly interact with adverse life events to alter the risk to develop symptoms of psychiatric disorders. Overall, our results
further validate Cacna1c as a cross-disorder risk gene in mice and humans, and additionally suggest a differential role for Cav1.2
during development and adulthood in shaping cognition, sociability, emotional behavior and stress susceptibility. This may prompt
the consideration for pharmacological manipulation of Cav1.2 in neuropsychiatric disorders with developmental and/or stress-
related origins.
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INTRODUCTION
Major psychiatric disorders including schizophrenia (SCZ), bipolar
disorder (BPD), major depressive disorder (MDD) and autism are
moderately to highly heritable, and increasing evidence is
suggesting a shared genetic etiology among them.1–6 This might
partially explain why many patients suffering from these illnesses
display a substantial amount of overlapping symptoms.7 One of
the most consistent and robust genetic ﬁndings from genome-
wide association studies (GWAS) and meta-analyses of GWAS are
associations of single-nucleotide polymorphisms (SNPs) in the α1
subunit (CACNA1C) of the voltage-gated L-type Ca2+ channel
(LTCC) Cav1.2 with SCZ and BPD, and to a lesser extent with MDD
and autism.1,8–16 In support, candidate analysis studies have
clearly indicated a shared genetic risk for CACNA1C across these
disorders.1,15,17 Further evidence comes from clinical studies,
which have associated the primary disease-associated CACNA1C
risk allele, rs1006737, with variations in human brain function and
structure in patients, but also in healthy subjects.18–20 Hence, the
available GWAS and clinical data establish CACNA1C as a possible
shared susceptibility factor which inﬂuences disease vulnerability
for BPD, SCZ and MDD across current diagnostic boundaries. This
is of considerable interest, in view of the fact that LTCCs have a
pivotal role in modulating neuronal excitability, synaptic plasticity
and gene expression.21–23 However, the causality and mechanisms
of how genetic alterations in CACNA1C affect the risk for an
entire spectrum of psychiatric disorders remain largely unknown.
Importantly, the associated CACNA1C variants by themselves only
confer a marginal increase in disease risk. In addition to shared
genetic risk factors, the environment represents an important
contributor to the risk for many psychiatric disorders. In particular,
adverse life events such as severe trauma and/or chronic stress
represent strong risk factors not only for MDD but also for other
psychiatric disorders including BPD and SCZ.24–26 However, no
study to date has examined whether the established risk gene
CACNA1C interacts with established environmental risk factors to
shape disease outcome.
Functional LTCCs are hetero-oligomeric complexes consisting of
multiple subunits: α1, β, α2, δ and/or γ. The voltage sensor,
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selectivity ﬁlter, ion-conduction pore and binding site for all
available calcium channel blockers is encoded by the α1 subunit.
The LTCC family consists of four distinct members, Cav1.1–Cav1.4,
with mainly Cav1.2 and Cav1.3 shown to have a prominent role in
the brain,19,22,23 and Cav1.2 accounting for ~ 85% of the LTCCs.
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Pharmacological agents, such as the LTCC-targeting dihydropyr-
idines, have frequently been applied to assess the function of
LTCCs in the central nervous system (CNS). However, this
approach is limited by the fact that all LTCC antagonists available
to date are not completely selective for either Cav1.2 or Cav1.3,
and that most studies investigated acute rather than long-term
effects. More sophisticated genetic approaches using transgenic
mice have helped to address the selective functional roles of
different LTCCs.19,22,23 Constitutive deletion of Cacna1c was shown
to result in embryonic lethality28 and conditional inactivation of
Cav1.2 in forebrain structures was repeatedly associated with
impairments in cognitive function.29–32 More recently, haplo-
insufﬁciency and forebrain-speciﬁc deletion of Cacna1c were
also associated with anxiety-like behavior33,34 and sleep distur-
bances,35 two core endophenotypes of MDD and BPD. In addition,
Cacna1c was shown to mediate survival of young hippocampal
neurons36 and brain-speciﬁc deletion of Cacna1c impairs discrete
forms of hippocampal-dependent memory and neurogenesis
within the dentate gyrus.37 However, the underlying neuronal
circuits that modulate the effects of CACNA1C on synaptic
plasticity and behavior remain largely unknown.
In this study we aimed to investigate how CACNA1C modulates
the risk to psychiatric disorders in dependence of environmental,
developmental and circuit speciﬁc factors, using both genetic
mouse models and human data.
MATERIALS AND METHODS
For a detailed description of the Materials and Methods, please refer to the
Supplementary Information.
Animals
Male mice were used for all experiments. Inactivation of Cacna1c from
forebrain glutamatergic neurons during development was achieved
by breeding Cacna1clox/lox mice29 to Nex-Cre mice,38 to obtain Cav1.2-
DevGlu-Ctrl (Cacna1clox/lox) and Cav1.2-DevGlu-CKO (Cacna1clox/lox:Nex-Cre).
Homozygous and heterozygous deletion of Cacna1c from forebrain
excitatory projection neurons in adulthood was achieved by breeding
Cacna1clox/lox mice to transgenic Camk2α-CreERT2 mice39 to obtain Cav1.2-
AdGlu-Ctrl (Cacna1clox/lox) and Cav1.2-AdGlu-CKO (Cacna1lox/lox:Camk2α-
CreERT2), as well as Cav1.2-AdGlu-Ctrl (Cacna1c+/lox) and Cav1.2-AdGlu-Het
(Cacna1+/lox:Camk2α-CreERT2), respectively. Cacna1c inactivation in Cav1.2-
AdGlu-CKO and Cav1.2-AdGlu-Het mice was induced via 2 weeks of tamoxifen-
containing food administration initiated during postnatal weeks 11–13.
Both, control (Ctrl) and conditional knockout (CKO; CKOhet) mice received
the identical tamoxifen diet. Behavioral experiments were started following
an additional two-week washout period in which Cav1.2-AdGlu-CKO and
Cav1.2-AdGlu-Het mice received regular chow. Adult male CNS-speciﬁc
Cacna1c knockout mice and Ctrl littermates were obtained by initially
breeding Cacna1clox/lox CKO with Nestin-Cre mice.40 Subsequently
Cacna1clox/lox mice were bred to Cacna1c− /+:Nestin-Cre mice to obtain
Cav1.2CNS-Ctrl (Cacna1c+/lox:Nestin-Cre) and Cav1.2CNS-CKO (Cacna1c− /lox:
Nestin-Cre). Heterozygous Cav1.2 mice and their Ctrl littermates were
obtained from the same breedings; Cav1.2Ctrl (Cacna1c+/lox) and Cav1.2Het
(Cacna1c− /lox). All animals were kept under standard laboratory conditions
and were maintained on a 12 h light–dark cycle (lights on from 0700
to 1900 h), with food and water provided ad libitum. All experiments were
conducted in accordance with the Guide for the Care and Use of
Laboratory Animals of the Government of Upper Bavaria, Germany.
Chronic social defeat stress paradigm
The chronic social defeat stress (CSDS) paradigm is commonly applied
to induce anxiety- and depression-related endophenotypes in mice,
and was performed as previously described.41–43 See also Supplementary
Information.
Behavioral testing and study design
Locomotion and sociability were investigated with the open ﬁeld (OF) test
and the three chamber apparatus respectively, as previously described.41,44
Anxiety-related behaviour was assessed in the light/dark box test as
previously described.45 Spatial memory learning and object recognition
were investigated with the water cross maze (WCM)46 and spatial object
recognition task. The forced swim test (FST) was used to assess passive vs
active stress-coping behavior (behavioral despair) and corticosterone levels
in response to an acute stressor as previously described.41 For details, refer
to online Supplementary Information.
For the basal behavioral characterization of Cav1.2-DevGlu-CKO (Figure 2),
Cav1.2-AdGlu-CKO (Figure 2) and Cav1.2CNS-CKO mice (Supplementary
Figure S7), one batch of animals was used for each line with the following
order of tests (OF, sociability, dark/light box test, FST and corticosterone
assessment). A second and third batch of animals was used for the WCM
test and long-term potentiation (LTP) recordings, respectively. In addition,
a fourth batch of Cav1.2-AdGlu-CKO mice (Figure 4) was used for the CSDS
paradigm with the following test order (sociability, OF, object recognition
test, dark/light box, FST and subsequent corticosterone, adrenal gland and
thymus weight assessment). The same applies to Cav1.2-AdGlu-Het mice
(Supplementary Figure S9). For the CSDS experiment in Cav1.2Het mice
(Figure 3), two separate batches of animals were used. For batch 1, the OF
and dark/light box test were performed. For batch 2, the following tests
were performed in this order: sociability, object recognition test, FST and
subsequent corticosterone, adrenal gland and thymus weight assessment.
Electrophysiology
The inﬂuence of Cacna1c deﬁciency on hippocampal LTP was conducted
as previously described.47 For details, please refer to online Supplementary
Information.
Single and double in situ hybridization
Single and double in situ hybridization (ISH) was performed as previously
described.48 The Cacna1c probe was designed to target the loxP ﬂanked
exons 14 and 15 (nucleotides 2307–2427 of GenBank accession number
NM_009781). In addition, the following riboprobes were used: Gad67: 984–
1940 of NM_008077; Gad65: 753–1600 of NM_008078; Vglut1 (Slc17a7):
1716–2332 of NM_010484; Vglut2 (Slc17a6): 2427–3006 of NM_080853.3;
and LacZ: 2649–3281 of X65335. Images were analyzed with ImageJ (http://
rsweb.nih.gov/ij/). Three to four independent experiments were performed
for all ISHs and double ISHs.
Study design (gene × environment interaction in humans)
Participants in this study belonged to a larger cohort (Grady Trauma
Project) investigating the role of genetic and environmental factors in
predicting outcomes to stressful life events.49–51 Phenotypes and
genotypes were available for a total of 4,023 individuals, predominantly
African Americans belonging to a highly traumatized, urban population
of low socioeconomic status. All procedures were approved by the
institutional review boards of Emory University School of Medicine and
Grady Memorial Hospital. Please see Supplementary Methods for further
details and statistics.
Statistical analysis
Statistical analyses were performed using the commercially available
software SPSS v16.0 (SPSS, Chicago, IL, USA) and GraphPad Prism v5.0
(GraphPad Software, La Jolla, CA, USA). The sample size was chosen such
that with a type 1 error of 0.05 and a type 2 error of 0.2 the effect size
should be at least 1.2-fold of the pooled s.d. All results are presented as
mean± s.e.m. Behavioral phenotypic differences between two geno-
types were evaluated with Student’s t-test (two-tailed). If data were not
normally distributed, the non-parametric Mann–Whitney test was used.
Time-dependent measures were assessed with multi-factorial analysis
of variance (ANOVA) with repeated measures. For CSDS experiments, the
effects of genotype and condition on all other behavioral and
neuroendocrine parameters were assessed by two factorial ANOVA (two-
way ANOVA). Whenever signiﬁcant main or interaction effects were found
by the ANOVAs, Bonferroni post hoc tests were carried out to locate simple
effects. Statistical signiﬁcance was deﬁned as Po0.05. All data were tested
for outlieres using the Grubb’ test. Homogeneity of variance was tested
using Bartlett’s test. Animals were allocated to the experimental groups in
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a semi-randomized manner and data analysis was performed blinded to
the group allocation.
RESULTS
Forebrain Cacna1c is predominately expressed in glutamatergic
neurons
Cacna1c is expressed throughout the mouse brain, including key
limbic regions relevant for emotion and cognition such as the
prefrontal cortex (Ctx), hippocampus (Hip) and amygdala
(Figure 1a). Double ISH against Cacna1c and markers of excitatory
glutamatergic (Vglut1 and Vglut2), as well as inhibitory GABAergic
neurons (Gad65/Gad67), revealed a predominant expression of
Cacna1c in glutamatergic Vglut1-positive neurons throughout the
Ctx, Hip and basolateral amygdala. The prominent Cacna1c
expression in the thalamus was largely restricted to glutamatergic
Vglut2-positive neurons, although a number of Cacna1c-contain-
ing neurons within the latero-dorsal thalamus also co-expressed
Vglut1 (Figures 1b and d and Supplementary Figure S1e,f). Minimal
to no co-expression with Vglut1 was detected in the caudate
putamen, central nucleus of the amygdala, bed nucleus of the stria
terminalis or granule cell layer of the olfactory bulb, conﬁrming
the abundance of GABAergic markers in these regions. Accord-
ingly, Cacna1c expression in the olfactory bulb, CPu, bed nucleus
of the stria terminalis and central nucleus of the amygdala was
mainly restricted to Gad65/67-positive GABAergic neurons. In
addition, Cacna1c was also detected in scattered Gad65/
67-positive neurons of the Hip and Ctx (Figures 1c and d and
Supplementary Figure S1c,d).
Deletion of Cacna1c from forebrain glutamatergic neurons during
development and adulthood induces differential effects on
anxiety and opposing effects on cognition
In view of the results described above, we set out to genetically
dissect the role of Cacna1c in glutamatergic neurons. For this, we
crossed ﬂoxed Cacna1c mice to Nex-Cre mice,38 in which Cre-
mediated recombination is initiated during embryonic develop-
ment (E11.5) in forebrain glutamatergic neurons. As observed
from the ISHs and double ISHs, Cacna1c ablation in forebrain
glutamatergic neurons (Cav1.2-DevGlu-CKO) was largely restricted to
Vglut1-expressing cells, including the Ctx, CA1/2/3 of the Hip, and
lateral and basolateral amygdala (Figures 2a and b, and
Supplementary Figures S2). Next, we assessed behavioral endo-
phenotypes known to be altered in animal models of MDD, BPD
and SCZ, including locomotion/exploration in the OF test, anxiety
in the dark/light box test, immobility in the FST, social behavior in
the three-chamber test (sociability test), as well as spatial learning
and memory in the WCM task. Similar to humans, deﬁcits
in cognition and social behavior are recapitulated by mouse
models of numerous psychiatric disorders including SCZ, BPD and
MDD.52–54 Hyperactivity in the OF and FST are often associated
with mania in mouse models of BPD,53,55 whereas enhanced
anxiety represents a core endophenotype of MDD and the
depressive phase of BPD in rodents.52 However, changes in
locomotor activity are also commonly reported in animal models
of SCZ and MDD.52,54 Compared with their respective littermate
Ctrls, Cav1.2-DevGlu-CKO mice exhibited increased anxiety in the
dark–light box test and decreased preference for the social
counterpart in the sociability test (Figures 2c and d). In the FST,
Cav1.2-DevGlu-CKO mice exhibited increased active stress-coping
behavior (reduced behavioral despair), evident by decreased
immobility (Figure 2e). In addition, Cav1.2-DevGlu-CKO mice
displayed a pronounced hyperlocomotion in the OF test, which
was not observed during the initial 5 min where novelty-induced
anxiety is most prominent (Figure 2f). The OF was performed
under low light conditions (15 lux) in order to minimize anxiety
effects on locomotion, which likely explains the lack of effects on
inner zone time (Figure 2f). Hip-dependent spatial learning and
memory performance was investigated in the WCM.46 Compared
with the regular Morris water-maze test, the simplicity of the WCM
leads to short trial durations and therefore reduces the stress load
compared to Morris water-maze training. In addition, using
accuracy rather than speed as the main readout, allows for
hippocampus-dependent strategies to be assessed from the ﬁrst
training day on. Cav1.2-DevGlu-CKO mice displayed accuracy levels
that barely surpassed the chance level of 50%, both during
learning and relearning (Figure 2g), suggesting drastically
impaired cognitive performance. In view of this strong effect on
cognition, we additionally assessed hippocampal LTP at the
Schaffer collateral-CA1 synapses. One hour after a 100 Hz tetanus
stimulation, Cav1.2-DevGlu-CKO showed a signiﬁcant decrease in LTP
compared with Ctrl mice (Figure 2h).
Next we addressed whether the underlying neurobiological
changes responsible for the behavioral alterations in Cav1.2-
DevGlu-CKO mice occur during development or adulthood. Floxed
Cacna1c mice were bred to inducible Camk2α-CreERT2 animals39
with the aim of deleting Cacna1c in forebrain glutamatergic
neurons (Cav1.2-AdGlu-CKO) during adulthood (postnatal weeks
11–13). We deliberately chose the Camk2α-CreERT2 line because of
the strongly overlapping expression pattern with the Nex-Cre line
(Figures 2a and i, and Supplementary Figures S2 and S5). Cav1.2
was inactivated upon tamoxifen administration in forebrain
excitatory projection neurons, which predominantly include
glutamatergic pyramidal neurons of the Ctx, Hip and basolateral
amygdala.39 As expected, the mRNA deletion pattern strongly
resembled that of Cav1.2-DevGlu-CKO mice, with loss of Cacna1c
expression in Vglut1-positive neurons of the lateral and basolateral
amygdala, as well as the entire cerebral Ctx and Hip (Figures 2i
and j, and Supplementary Figures S3 and S4). Along these lines,
remaining hippocampal protein levels did not signiﬁcantly differ
between Cav1.2-DevGlu-CKO and Cav1.2-AdGlu-CKO(Supplementary
Figure S6a,b). In addition, deletion of Cacna1c mRNA expression
in Cav1.2-DevGlu-CKO mice was also observed throughout the DG
and within a few neurons of the latero-dorsal thalamus and medial
parts of the thalamus, central nucleus of the amygdala and the
geniculate nucleus (Supplementary Figures S2). In the OF, Cav1.2-
AdGlu-CKO mice displayed enhanced locomotion (Figure 2n),
although this was not as strongly pronounced as in Cav1.2-
DevGlu-CKO mice. However, immobility in the FST and sociability
were not signiﬁcantly altered in Cav1.2-DevGlu-CKO mice (Figures 2l
and m). Surprisingly, Cav1.2-AdGlu-CKO mice displayed a marginal
increase in time spent in the lit zone and number of entries in the
dark/light box test (Figure 2k), and even demonstrated enhanced
cognitive ﬂexibility during the relearning trial of the WCM
(Figure 2o). Considering that deletion of forebrain Cacna1c was
reported to impair long-term memory,32 we re-exposed the
animals to the WCM 30 days after relearning, but did not observe
any differences between Cav1.2-AdGlu-CKO and Ctrl mice
(Supplementary Figure S6g). In view of our results that develop-
mental inactivation of Cacna1c from glutamatergic neurons
decreases NMDA receptor (NMDAR)-dependent synaptic plasticity
and impairs spatial memory, we additionally assessed hippocam-
pal LTP in Cav1.2-AdGlu-CKO mice. Intriguingly, 1 h after a 100 Hz
tetanus stimulation, Cav1.2-AdGlu-CKO showed increased LTP
compared with Ctrl mice (Figure 2p). Importantly, we observed
that CNS-speciﬁc Cacna1c deletion (Cav1.2CNS-CKO mice), which is
initiated at E8,56 results in similar behavioral alterations compared
with Cav1.2-DevGlu-CKO mice (Supplementary Figure S7). This
further supports partially opposing roles for developmental and
adult Cacna1c in emotion and cognition, and argues against the
possibility that differences between Cav1.2-DevGlu-CKO and Cav1.2-
AdGlu-CKO mice are due to the slight discrepancies in recombina-
tion patterns between the Nex-Cre and Camk2a-CreERT2. In
addition, the observed behavioral changes were not caused by
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Figure 1. Cacna1c is predominantly expressed in forebrain glutamatergic neurons. (a) Cacna1c mRNA expression in the mouse brain (C57BL/6J
mouse strain), determined by in situ hybridization (ISH). (b and c) Co-localization of Cacna1c with glutamatergic (Vglut1) and GABAergic
(Gad65/67) markers with double ISH (DISH). Black arrowheads indicate cells only expressing Cacna1c (silver grains). Gray arrowheads indicate
cells co-expressing Cacna1c and the respective neurotransmitter marker (red staining). (d) Quantiﬁcations of Cacna1c co-expression with
Vglut1 and Gad65/67 (n= 3, 2–3 sections per mouse). Scale bar= ISH, 1 mm; DISH, 50 μm.
Figure 2. Absence of Cacna1c in forebrain glutamatergic neurons during development, but not adulthood, promotes aversive behavioral and
cognitive deﬁcits. (a) Cacna1c expression pattern determined by in situ hybridization (ISH) following developmental deletion of Cacna1c (E11.5)
in forebrain glutamatergic neurons (Cav1.2-DevGlu-CKO). (b) Double ISH (DISH) in Cav1.2-DevGlu-CKO mice demonstrates absence of Cacna1cmRNA
expression (silver grains) in Vglut1-positive neurons (red staining) in the hippocampal CA3 region (conditional knockout (CKO)= 3.6± 0.74%
double-positive neurons normalized to control (Ctrl); one-way analysis of variance (ANOVA): F1,11= 365.4, Po0.0001, n= 4, 1–2 sections per
mouse). Enlarged images of boxed areas are shown in the bottom panel. (c) Dark/light box test (lit time: t26= 2.7, Po0.05; No. lit entries:
t26= 2.2, Po0.05; n= 16 Ctrl, 12 CKO). (d) Sociability test (t26= 2.9, Po0.05; n= 16 Ctrl, 12 CKO). (e) Forced swim test (FST; t26= 3.6, Po0.005;
n= 16 Ctrl, 12 CKO). (f) Distance travelled an inner zone time in the open ﬁeld (OF) test (distance segments: repeated measures (RM)-ANOVA:
time × genotype: F5,130= 5.7, Po0.0001; genotype: F(1,130)= 45.9, Po0.001; total distance: t26= 6.8, Po0.0001; n= 16 Ctrl, 12 CKO). (g) Water
cross-maze test (RM-ANOVA: genotype: F1,88= 7.5, Po0.05; time ×genotype: F4,88= 7.3, Po0.0001; n= 13 Ctrl, 11 CKO). (h) Schaffer collateral/
CA1-long-term potentiation (LTP) in Cav1.2-DevGlu-CKOmice (fEPSP last 10 min: t24= 2.36, Po0.05; n= 14 slices from 4 Ctrl mice and 12 slices
from 4 CKO mice (i) Cacna1c expression pattern determined by ISH following adult-speciﬁc deletion (postnatal week 11–13) of Cacna1c in
forebrain glutamatergic neurons (Cav1.2-AdGlu-CKO). (j) DISHs in Cav1.2-AdGlu-CKO mice demonstrated the absence of Cacna1c mRNA expression
in Vglut1-positive neurons in the hippocampal CA3 region (CKO= 4.5± 1.6% double-positive neurons normalized to Ctrl; one-way ANOVA:
F1,11= 365.4, Po0.0001, n= 4, 1–2 sections per mouse). Enlarged images of boxed areas are shown in the bottom panel. (k–m) Dark/light box,
sociability and FST (t= trend, P= 0.09, n= 17 Ctrl, 11 CKO) in Cav1.2-AdGlu-CKO mice. (n) OF test (distance segments: RM-ANOVA: genotype,
F1,130= 9.06, Po0.05; total distance: t26= 3.01, Po0.05; n= 17 Ctrl, 11 CKO) in Cav1.2-AdGlu-CKO mice. (o) Water cross-maze test (RM-ANOVA:
genotype, F1,80= 4.36, Po0.05; n= 11 Ctrl, 10 CKO) in Cav1.2-AdGlu-CKO mice. (p) Schaffer collateral/CA1-LTP in Cav1.2-AdGlu-CKO mice (fEPSP last
10 min: t27= 2.06, Po0.05; n= 13 slices from 6 Ctrl mice and 16 slices from 7 CKO mice). Student’s t-test for simple comparisons, *Po0.05.
Data are means± s.e.m.
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alterations in hypothalamic-pituitary-adrenal axis function in
neither of the mouse lines (Supplementary Figures S6c,d).
Cacna1c differentially modulates susceptibility to CSDS during
development and adulthood
Chronic stress and/or trauma represent strong risk factors for a
number of psychiatric disorders, including MDD, BPD and anxiety
disorders such as post-traumatic stress disorder.24–26,57 In view of
the phenotype in Cav1.2-DevGlu-CKO mice, we wondered whether
developmental deletion of Cacna1c would increase the suscept-
ibility to CSDS. We choose to investigate heterozygous Cacna1c
animals (Cav1.2Het, Figure 3a), considering that Cav1.2-DevGlu-CKO
mice already display strong behavioral deﬁcits under baseline
conditions, which might not be further aggravated by CSDS.
Importantly, no gross behavioral abnormalities were previously
reported for Cav1.2Het mice.33 Cav1.2Ctrl and Cav1.2Hetmice were
subjected to 3 weeks of CSDS. In accordance with other studies,41,42
we were able to detect robust physiological and neuroendocrine
changes evoked by CSDS, independent of genotype, demonstrating
the efﬁcacy of the paradigm (Supplementary Figures S8a–d).
Chronically stressed Cav1.2Het mice displayed drastically reduced
locomotion throughout the entire test duration compared to both,
non-stressed Cav1.2Het and stressed Cav1.2Ctrl mice (Figure 3b). In
addition, only chronically stressed Cav1.2Het mice showed a
signiﬁcant reduction in the number of inner zone entries of the
OF, indicating increased anxiety-related behavior even under low-
light test conditions (Figure 3c). Moreover, CSDS increased the
latency to enter the lit compartment and decreased the time spent
in the lit zone and number of lit entries to a much greater extent in
Cav1.2Het than in Cav1.2Ctrl mice (Figures 3d–f), further supporting
increased stress-induced anxiety in heterozygous Cacna1c mice.
Sociability, immobility in the FST and spatial object recognition
memory were not differentially affected by CSDS (Figures 3g–i),
suggesting a speciﬁc impact of the interaction between Cacna1c
and chronic stress on anxiety.
In view of the partially opposing effects of Cacna1c on anxiety
and cognition during development and adulthood, we wondered
whether stress vulnerability would also be differentially affected
upon deletion of the calcium channel in adulthood. Physiological
and neuroendocrine parameters were similarly altered by CSDS in
Ctrl and Cav1.2-AdGlu-CKO mice (Supplementary Figures 8e–h). In
contrast to Cav1.2Het mice, locomotion/exploration in the OF was
only decreased in stressed Ctrl but not stressed Cav1.2-AdGlu-CKO
mice, with a similar trend in the number of inner zone entries
(Figures 4a and b). In the dark/light box test, only Ctrl mice
responded to CSDS with a signiﬁcant reduction in time spent in
the lit zone and number of entries, and a trend toward delayed
latencies (Figure 4c), which implies enhanced resilience to CSDS in
Cav1.2-AdGlu-CKO mice. FST behavior, sociability and spatial object
were similarly affected by CSDS in Ctrl and Cav1.2-AdGlu-CKO mice
(Figures 4d–f). Considering that we observed susceptibility to
CSDS in heterozygous Cav1.2 mice, we additionally assessed
whether a heterozygous deletion in glutamatergic neurons during
adulthood (Cav1.2-AdGlu-Het) would be sufﬁcient to induce stress
resilience (Supplementary Figure S9). However, compared with
Cav1.2-AdGlu-CKO, Cav1.2-AdGlu-Het mice only exhibited partial
resilience to CSDS-induced anxiety in the dark/light box test
(Supplementary Figure S9f). This points to a gene-dosage effect
and suggests that complete absence of Cacna1c during adult-
hood, in forebrain glutamatergic neurons, is required to induce
the extent of resilience to CSDS observed in Cav1.2-AdGlu-CKOmice.
CACNA1C interacts with adult trauma to predict depression
symptoms in humans
A number of CACNA1C SNPs associated with BPD, SCZ and
MDD were also shown to affect measures of anxiety, depression,
Figure 3. Cacna1c heterozygosis induces susceptibility to chronic social defeat stress (CSDS). (a) Cacna1c in situ hybridization (ISH) in control
(Ctrl) and Cav1.2Het (Het) mice, in which heterozygosis is present from the ﬁrst day of development. (b) Locomotion (distance segments:
time×genotype × stress, F(2,41)= 4.3, P= 0.02/total distance: genotype, F1,42= 23.6, Po0.0001; stress, F1,42= 25.4, Po0.0001; genotype × stress,
F1,42= 4.9, P= 0.033) and (c) number of inner zone entries (stress × genotype, F1,42= 5.1, P= 0.03; stress, F1,42= 18.1, Po0.0001; genotype,
F1,42= 16.3, P= 0.0002) in the open ﬁeld (OF) test (n= 12 Ctrl basal, 15 Ctrl stress, 10 Het basal, 9 Het stress). (d–f) Dark/light box test (Lit zone
time: stress × genotype, F1,44= 8.40, P= 0.006; stress, F1,44= 21.2, Po0.0001; genotype, F1,44= 6.6, P= 0.01/Lit zone entries: stress, F1,44= 26.1,
Po0.0001; genotype, F1,44= 16.3, Po0.0001; n= 14 Ctrl basal, 15 Ctrl stress, 10 Het basal, 9 Het stress). (g–i) Sociability test (stress, F1,35= 8.0,
P= 0.008), forced swim test (FST; genotype, F1,35= 5.6, P= 0.01) and spatial object recognition test (n= 9 Ctrl basal, 10 Ctrl stress, 10 Het basal,
10 Het stress). Two-way analysis of variance (ANOVA)+Bonferroni post hoc test and repeated measures (RM)-ANOVA+Bonferroni post hoc test;
*signiﬁcantly different from the Ctrl group of the same condition, #signiﬁcantly different from the basal condition of the same genotype. Data
are means± s.e.m.
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psychosocial functioning and cognitive aspects in healthy
Ctrls,58 which might represent increased susceptibility factors for
psychiatric disorders upon exposure to adverse environ-
ments. This is especially interesting in the context of MDD, in
which disease susceptibility is strongly inﬂuenced by previous
exposures to chronic and/or severe stress. Considering that most
GWAS do not Ctrl for life-time adversity, we wondered whether
certain CACNA1C SNPs might primarily inﬂuence the risk for MDD
in combination with stressful life events. Consequently, we
analyzed the effects of all CACNA1C variants and adult trauma
on current depression symptoms, determined by the Beck
Depression Inventory59 in a large African American cohort of
non-psychiatric clinical patients (n= 4808) from the Grady trauma
project.49,50,60 Importantly, symptoms of depression are not only
characteristic for MDD and BPD but can also occur as part of
affective dysregulation in SCZ24. After linkage disequilibrium-
pruning based on r2-values of 0.2, 32 of the 465 tested SNPs in the
CACNA1C locus showed nominal signiﬁcant interactions with
adult trauma exposure on Beck Depression Inventory scores. Of
these, two remained signiﬁcant after Bonferroni correction for
multiple testing; rs73248708, nominal P= 1.38 × 10− 5, Bonferroni
corrected P= 0.0004; rs116625684, nominal P= 5.2 × 10− 5, Bonfer-
roni corrected P= 0.0016 (Figures 5a and b, and Supplementary
Table S1 and S2). Both SNPs also showed nominal signiﬁcant main
effects (rs73248708: nominal P= 1.88 × 10− 4, rs116625684: nom-
inal P= 0.02). Interestingly, in both cases, individuals carrying at
least one minor allele (CT/TT or AG/AA) and without trauma
history displayed signiﬁcantly higher Beck Depression Inventory
Figure 4. Deletion of Cacna1c from forebrain glutamatergic neurons during adulthood promotes resilience to chronic social defeat stress
(CSDS). (a) Locomotion (distance segments: time× stress, F2,45= 10.7, Po0.0001/total distance: genotype, F1,45= 19.6, Po0.0001; stress,
F1,45= 4.3, P= 0.04) and (b) number of inner zone entries in the open ﬁeld (OF). (c) Dark/light box test (Lit zone time: genotype, F1,45= 9.3,
P= 0.004/Lit zone entries: stress, F1,45= 5.8, P= 0.02; genotype, F1,45= 12.3, Po0.001). (d) Sociability test (stress, F1,45= 52.52, Po0.0001) and
(e) forced swim test (FST; genotype, F1,45= 7.5, P= 0.009; stress, F1,45= 8.3, P= 0.006). (f) Spatial object recognition test (stress, F1,42= 7.1,
P= 0.01). Two-way analysis of variance (ANOVA)+Bonferroni post hoc test and repeated measures (RM)-ANOVA+Bonferroni post hoc test;
*signiﬁcantly different from the control (Ctrl) group of the same condition, #signiﬁcantly different from the basal condition of the same
genotype. OF, dark/light box test, sociability and FST (n= 13 Ctrl basal, 12 Ctrl stress, 12 conditional knockout (CKO) basal, 12 Het stress).
Spatial object recognition test (n= 12 Ctrl basal, 10 Ctrl stress, 12 CKO basal, 12 CKO stress). Data are means± s.e.m.
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scores compared with the major allele group, whereas the
opposite was observed for minor allele carriers with the highest
degree of lifetime trauma exposure.
DISCUSSION
Our results demonstrate that spatial memory, hippocampal
plasticity and anxiety-related behavior are differentially affected
by the loss of Cacna1c from excitatory circuits depending on
whether it is deleted during embryonic development or adult-
hood. Increased anxiety-related behavior as well as reduced social
and cognitive performance, observed in Cav1.2-DevGlu-CKO mice,
are considered core endophenotypes of MDD and/or the
depressive phase of BPD,52,53 whereas increased locomotion and
activity in the FST are often associated with mania in animal
models of BPD.53,55 Decreased immobility in the FST was
previously reported for heterozygous mice by Dao et al.,33 which
is in line with our results and earlier work demonstrating
antidepressant-like effects for LTCC blockers.27,61 However, studies
using LTCC blockers have to be interpreted with caution, as these
have been reported to induce nonspeciﬁc, aversive and stress-like
behavioral effects possibly due to excessive blood pressure
lowering caused by inhibition of Cav1.2 in the cardiovascular
system.62–64 Importantly, hyperlocomotion, altered social beha-
vior, and learning and memory impairments, are also analogous to
negative and cognitive symptoms of SCZ, a disorder believed to
have neurodevelopmental origins.24,54 Additional evidence also
suggests that two missense mutations in CACNA1C predispose to
autism,65,66 another neurodevelopmental disorder characterized
by impaired social interactions and altered cognition. In accor-
dance with the observed cognitive impairments, Cav1.2-DevGlu-CKO
mice also displayed deﬁcits in hippocampal LTP, which is
considered the cellular correlate of learning and memory.67
Moreover, we show that Cacna1c strongly interacts with the
environment to shape anxiety-related behavior. Heterozygous
deletion of Cacna1c, which is present throughout life starting at
the earliest point of development (one-cell stage), signiﬁcantly
increased the susceptibility to CSDS and is likely to be mediated
by Cacna1c absence in forebrain glutamatergic neurons. Although
CACNA1C SNPs have not been consistently associated with anxiety
in humans, altered anxiety-related behavior is considered a core
endophenotype of MDD and BPD in animal models.52,53,55
Different to our observations, a recent study showed that chronic
unpredictable stress induces similar behavioral deﬁcits in hetero-
zygous Cav1.2 mice and their wild-type littermates when assessed
1–2 days post stress. Surprisingly, the stress effects persisted in
wild-type mice when tested 5–7 days later but not in hetero-
zygous knockout mice.68 These discrepancies might be related to
the different chronic stress paradigms.
In contrast to a developmental inactivation, deletion of
Cacna1c from forebrain glutamatergic neurons during adulthood
blocked the adverse effects of CSDS on anxiety, enhanced LTP and
improved hippocampus-dependent cognitive ﬂexibility during the
WCM, without affecting long-term memory. Our ﬁndings in
Cav1.2-DevGlu-CKO mice are supported by previous studies, showing
that deletion of Cacna1c from pan-neuronal37 or glutamatergic
neurons during development29 impairs synaptic plasticity
and/or spatial learning, some of which might be attributed to
deﬁcits in adult neurogenesis.37 However, it should be kept in
mind that our LTP results cannot be entirely correlated with
cognitive performance considering that we stimulated CA3-CA1
Schaffer collaterals, which leads to the potentiation of most CA3-
CA1 synapses rather than those that would selectively be recruited
during a learning and memory task. Electrophysiological and
Figure 5. CACNA1C interacts with adult trauma to predict depressive symptoms in humans. (a) Single-nucleotide polymorphism (SNP)
localization sites in the human CACNA1C locus. Exons are indicated with vertical black bars. (b) rs73249708 (P= 0.0004) and rs116625684
(P= 0.0016) signiﬁcantly interacted with adult trauma to predict Beck Depression Inventory scores. Asterisk indicate an interaction P-value
below 0.0016, hence surviving Bonferroni correction. The phenotype on adult trauma was categorized into its four quartiles to facilitate
interpretation of the plot. Sample size for individual genotypes: rs73248708 (n= 4106 GG, 331 AG, 7 AA), rs116625684 (n= 4372 AA, 367 AG, 7
GG). Data are means± s.e.m.
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pharmacological data have indicated that LTP induction is mainly
initiated through NMDAR-activity but can also include NMDAR-
independent and VGCC-dependent mechanisms.69,70 Interestingly,
the decline of some memory processes is attributed to the shift
from NMDAR-dependent to VGCC-intracellular calcium stores-
dependent regulation of synaptic plasticity, especially during
aging.71–73 Along these lines, a recent study provides evidence for
an association between increased hippocampal Cacna1c expres-
sion and age-related cognitive decline.74 Although we did not
assess aged animals, it can be speculated that ablation of Cav1.2 in
adulthood partially blocks an evolving shift towards VGCC- and/or
intracellular calcium store-dependent regulation of synaptic
plasticity, hence facilitating NMDAR-dependent LTP. This poten-
tially suggests that Hip-dependent spatial memory formation
requires Cav1.2 during prenatal development, but not in adult-
hood where activation of Cav1.2 channels is even detrimental
for LTP. Notably, calcium channel antagonists were shown to
ameliorate age-related deﬁcits in hippocampus-dependent
memory, possibly mediated through facilitation of NMDAR-LTP
or inhibition of long-term depression.71,73,75–78 On the other hand,
speciﬁc inactivation of Cacna1c in the anterior cingulate between
postnatal weeks 8–10, impaired observational fear learning
without altering novel object recognition memory and classical
fear conditioning,30 highlighting the requirement for Cav1.2
during adulthood for speciﬁc cognitive functions. The fact that
we observed no signiﬁcant changes in spatial object memory
performance under basal or stress conditions further implies that
adult-speciﬁc Cacna1c deletion in excitatory circuits does not
impact all cognitive domains.
As observed in Cav1.2-DevGlu-CKO mice, locomotion was also
enhanced in Cav1.2-AdGlu-CKO animals; however, social and active
stress-coping behavior were only mildly affected, suggesting that
these endophenotypes are partly regulated by forebrain-Cav1.2
during development and adulthood. In contrast, an earlier study
demonstrated that forebrain-speciﬁc elimination of Cacna1c, using
a non-inducible Camk2α-Cre, also results in increased anxiety-like
behavior.34 The discrepancy could potentially be attributed to
different Cacna1c deletion time windows (p1879 vs p91-97 in our
study).
Although the Nex-Cre and Camk2α-CreERT2 drivers primarily
target glutamatergic forebrain neurons, they do slightly differ in
their recombination patters (for example,the Camk2α-driven
CreERT2 is also expressed in parts of the thalamus, DG and central
nucleus of the amygdala). However, the fact that developmental,
CNS-speciﬁc Cacna1c knockout mice showed similar behavioral
deﬁcits as Cav1.2-DevGlu-CKO mice, further supports opposing roles
for Cav1.2 during development and adulthood. Nevertheless, we
cannot rule out an important contribution of Cav1.2-expressing,
GABAergic neurons in many of the disease-associated pheno-
types. In fact, Cacna1c was reported to modulate processes related
to drug addiction via GABAergic medium spiny neurons in the
nucleus accumbens,80,81 and promote susceptibility to social stress
when deleted from this speciﬁc brain region.82 It is important to
point out that we only assessed a subset of behavioral tests
relevant to MDD, BPD and SCZ in our knockout mice. Future
studies evaluating anhedonia, psychostimulant-induced locomo-
tion, sleep architecture and deﬁcits in sensorimotor gating
(prepulse inhibition deﬁcits), will further reﬁne the contribution
of developmental vs adult Cav1.2 in psychiatric disorders.
Given our observations in mice, we further investigated if
Cacna1c x stress interactions could also be found in human
samples and checked for interaction effects of CACNA1C variants
and adult trauma to predict current depressive symptoms
As expected, the risk to develop depressive symptoms was
increased with exposure to adult trauma in our study and this
effect was moderated by loci within CACNA1C tagged by
rs73248708 and rs116625684. Both tag SNPs were not in linkage
disequilibrium with the main haplotypes associated with SCZ with
genome-wide signiﬁcance, but represent independent loci. The
intron 1 SNP rs116625684 shows a weak, nominal association with
SCZ in the Psychiatric Genomics Consortium data set (P= 0.021),
with an odds ratio of 0.94 (http://www.med.unc.edu/pgc),
suggesting a protective effect of the minor allele, which is also
indicated by our results for the highest trauma group. The second
SNP, rs73248708 is located in intron 3, which harbors the majority
of CACNA1C SNPs associated with SCZ at genome-wide signiﬁ-
cance and also those linked to other disorders including BPD and
MDD.19 In fact, SNPs in this region were shown to lie in predicted
enhancers capable of physically interacting with the CACNA1C
transcriptional start site, and altering gene expression.83 Although
rs73248708 is not in linkage disequilibrium with the top GWAS
SNPs, including rs1006737, it may independently moderate the
function of this enhancer region. In fact, we could show that
different sets of genetic variants may be involved in baseline
transcriptional regulation vs. regulation following environmental
impact, such as trauma exposure.84 Replication in independent
cohorts will be necessary to further validate these loci in gene ×
environment interactions. Importantly, it remains to be investi-
gated whether the here identiﬁed SNPs have implications on
protein levels or are of other functional relevance. So far, both
decreased and increased Cav1.2 levels have been associated with
the common risk allele variant rs1006737,85–87 which might imply
different regulatory functions across different brain regions and/or
cell types. Whether the here identiﬁed SNPs, as well as previously
associated CACAN1C risk alleles, can differentially affect gene
expression in the brain upon perturbations such as severe stress
and/or trauma will have to be assessed in the future. Considering
the heterogeneity of MDD, our data raises the possibility that SNPs
in CACNA1C might predict the risk for depression mainly in
individuals with a history of trauma or severe stress. This could
partially explain the nominal associations of CACAN1C with MDD
in former genetic studies, which usually do not Ctrl for
environmental factors. In addition, given our animal ﬁndings it
would be interesting to examine for age × trauma interaction
effects in the human sample. However, in the present cohort we
did not have any information with regard to when exactly adult
trauma took place and therefore cannot evaluate age effects.
There are some limitations of the interpretability of our ﬁndings,
which should not be neglected. First, the Grady Trauma Project
includes mostly African Americans. We cannot rule out that effects
of CACNA1C variants are different in this speciﬁc population as
compared with the European population where the effect of
CACNA1C variants with regard to MDD were described ﬁrst.
Second, the GRADY sample itself is a highly traumatized cohort. It
is possible that the described effects are only present in samples
which show a high trauma burden and cannot be found in less
traumatized cohorts. However, ﬁndings in this cohort can help to
transit the results from mice to human data.
Although circuit- or cell type-speciﬁc absence of CACNA1C is
not likely to occur in humans, epigenetic changes caused by
environmental alterations may very well induce expression
changes in speciﬁc tissues, cell types and/or entire brain circuits.
In the clinical context this could imply that, individuals with
genetic variants promoting reduced CACNA1C expression may
either be at higher or lower risk to develop psychopathologies,
depending on whether they experienced severe stress/trauma
during development or adulthood. The pronounced effect of a
prenatal Cacna1c depletion on emotional behavior and cognitive
performance might account for its association with disorders such
as SCZ and autism, which are increasingly believed to result from
synaptic dysfunction during development. The fact that CACNA1C
is also able to interact with the environment during adulthood, by
modulating stress susceptibility, could explain its linkage to stress-
related disorder such as MDD and BPD. At the same time, Cav1.2
and Cav1.3 are expressed in midbrain dopaminergic neurons and
several studies suggest a neuroprotective effects of LTCC blockers
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in Parkinson’s disease,22,88 which further emphasizes the possibi-
lity that inhibition of Cav1.2 may be of therapeutic value in brain
disorders that manifest at later stages in life. Concluding,
we propose that the association of CACNA1C with multiple
psychiatric disorders is related to its broad expression within key
limbic regions and neuronal circuits relevant to emotion,
motivation and cognition, and that alterations in CACNA1C gene
expression during development and adulthood can result in
diverging behavioral outcomes and differentially impact stress
susceptibility.
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